Transmembrane oligomeric form of Vibrio cholerae cytolysin triggers TLR2/TLR6-dependent proinflammatory responses in monocytes and macrophages

Biochemical Journal

Volumn 466, Issue , 2015, Pages 147-161

  Khilwani, Barkha ^a   Mukhopadhaya, Arunika ^b   Chattopadhyay, Kausik ^a  

^a INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH MOHALI   (India)

^b Department of Biological Sciences IndiaInstitute of Science Education and Research ^*  (India)

Author keywords

Bacterial toxins; Macrophages; Monocytes; Proinflammatory response; Toll like receptors; Vibrio cholerae cytolysin.

Indexed keywords

CYTOLYSIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; MYELOID DIFFERENTIATION FACTOR 88; OLIGOMER; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 6; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; BACTERIAL TOXIN; MYD88 PROTEIN, HUMAN; PERFORIN; TLR2 PROTEIN, HUMAN; TLR6 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; INFLAMMATION; INNATE IMMUNITY; LIPOSOME MEMBRANE; MACROPHAGE; MOLECULAR INTERACTION; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; VIBRIO CHOLERAE; ANIMAL; CELL LINE; CELL MEMBRANE; CELL SURVIVAL; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOLOGY; PRIMARY CELL CULTURE;

BACTERIA (MICROORGANISMS); EUKARYOTA; VIBRIO CHOLERAE;

ANIMALS; BACTERIAL TOXINS; CELL LINE; CELL MEMBRANE; CELL SURVIVAL; GENE EXPRESSION REGULATION; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATION; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MACROPHAGES; MICE; MONOCYTES; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; PERFORIN; PRIMARY CELL CULTURE; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 6; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 6; TRANSCRIPTION FACTOR AP-1; VIBRIO CHOLERAE;

EID: 84922368733     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20140718     Document Type: Article

References (70)

1. Honda, T. and Finkelstein, R.A. (1979) Purification and characterization of a hemolysin produced by Vibrio cholerae biotype El Tor: another toxic substance produced by cholera vibrios. Infect. Immun. 26, 1020-1027
2. Ichinose, Y., Yamamoto, K., Nakasone, N., Tanabe, M.J., Takeda, T., Miwatani, T. and Iwanaga, M. (1987) Enterotoxicity of El Tor-like hemolysin of non-O1 Vibrio cholerae. Infect. Immun. 55, 1090-1093
3. Alouf, J.E. and Popoff, M.R. (2006) In The Comprehensive Sourcebook of Bacterial Protein Toxins, Academic Press, London
4. Kaper, J., Fasano, A. and Trucksis, M. (1994) Toxins of Vibrio cholerae. In Vibrio cholerae and Cholera: Molecular to Global Perspectives (Wachsmuth, I.K., Blake, P.A. and Olsvik, O., eds), pp. 145-176, ASM Press, Washington, D.C.
5. Kaper, J.B., Morris, Jr, J.G. and Levine, M.M. (1995) Cholera. Clin. Microbiol. Rev. 8, 48-86
6. Goldberg, S.L. and Murphy, J.R. (1984) Molecular cloning of the hemolysin determinant from Vibrio cholerae El Tor. J. Bacteriol. 160, 239-244
7. Yamamoto, K., Al-Omani, M., Honda, T., Takeda, Y. and Miwatani, T. (1984) Non-O1 Vibrio cholerae hemolysin: purification, partial characterization, and immunological relatedness to El Tor hemolysin. Infect. Immun. 45, 192-196
8. Chakraborty, D.C., Mukherjee, G., Banerjee, P., Banerjee, K.K. and Biswas, T. (2011) Hemolysin induces Toll-like receptor (TLR)-independent apoptosis and multiple TLR-associated parallel activation of macrophages. J. Biol. Chem. 286, 34542-34551
9. Gutierrez, M.G., Saka, H.A., Chinen, I., Zoppino, F.C., Yoshimori, T., Bocco, J.L. and Colombo, M.I. (2007) Protective role of autophagy against Vibrio cholerae cytolysin, a pore-forming toxin from V. cholerae. Proc. Natl. Acad. Sci. U.S.A. 104, 1829-1834
10. Coelho, A., Andrade, J.R., Vicente, A. C. P. and Dirita, V.J. (2000) Cytotoxic cell vacuolating activity from Vibrio cholerae hemolysin. Infect. Immun. 68, 1700-1705
11. De, S. and Olson, R. (2011) Crystal structure of the Vibrio cholerae cytolysin heptamer reveals common features among disparate pore-forming toxins. Proc. Natl. Acad. Sci. U.S.A. 108, 7385-7390
12. Olson, R. and Gouaux, E. (2005) Crystal structure of the Vibrio cholerae cytolysin (VCC) pro-toxin and its assembly into a heptameric transmembrane pore. J. Mol. Biol. 350, 997-1016
13. Gonzalez, M., Bischofberger, M., Pernot, L., van der Goot, F. and Frecirc;che, B. (2008) Bacterial pore-forming toxins: The (w)hole story? Cell. Mol. Life Sci. 65, 493-507
14. Heuck, A.P., Tweten, R.K. and Johnson, A.E. (2001) Beta-barrel pore-forming toxins: intriguing dimorphic proteins. Biochemistry 40, 9065-9073
15. Iacovache, I., Bischofberger, M. and van der Goot, F.G. (2010) Structure and assembly of pore-forming proteins. Curr. Opin. Struct. Biol. 20, 241-246
16. Tilley, S.J. and Saibil, H.R. (2006) The mechanism of pore formation by bacterial toxins. Curr. Opin. Struct. Biol. 16, 230-236
17. Ikigai, H., Akatsuka, A., Tsujiyama, H., Nakae, T. and Shimamura, T. (1996) Mechanism of membrane damage by El Tor hemolysin of Vibrio cholerae O1. Infect. Immun. 64, 2968-2973
18. Krasilnikov, O.V., Muratkhodjaev, J.N. and Zitzer, A.O. (1992) The mode of action of Vibrio cholerae cytolysin. The influences on both erythrocytes and planar lipid bilayers. Biochim. Biophys. Acta 1111, 7-16
19. Menzl, K., Maier, E., Chakraborty, T. and Benz, R. (1996) HlyA hemolysin of Vibrio cholerae O1 biotype E1 Tor. Identification of the hemolytic complex and evidence for the formation of anion-selective ion-permeable channels. Eur. J. Biochem. 240, 646-654
20. Yuldasheva, L.N., Merzlyak, P.G., Zitzer, A.O., Rodrigues, C.G., Bhakdi, S. and Krasilnikov, O.V. (2001) Lumen geometry of ion channels formed by Vibrio cholerae El Tor cytolysin elucidated by nonelectrolyte exclusion. Biochim. Biophys. Acta 1512, 53-63
21. Zitzer, A., Walev, I., Palmer, M. and Bhakdi, S. (1995) Characterization of Vibrio cholerae El Tor cytolysin as an oligomerizing pore-forming toxin. Med. Microbial. Immunol. 184, 37-44
22. Rai, A.K., Paul, K. and Chattopadhyay, K. (2013) Functional mapping of the lectin activity site on the β -prism domain of Vibrio cholerae cytolysin implications for the membrane pore-formation mechanism of the toxin. J. Biol. Chem. 288, 1665-1673
23. Paul, K. and Chattopadhyay, K. (2014) Pre-pore oligomer formation by Vibrio cholerae cytolysin: insights from a truncated variant lacking the pore-forming pre-stem loop. Biochem. Biophys. Res. Commun. 443, 189-193
24. Paul, K. and Chattopadhyay, K. (2012) Single point mutation in Vibrio cholerae cytolysin compromises the membrane pore-formation mechanism of the toxin. FEBS J. 279, 4039-4051
25. Zitzer, A., Palmer, M., Weller, U., Wassenaar, T., Biermann, C., Tranum-Jensen, J. and Bhakdi, S. (1997) Mode of primary binding to target membranes and pore formation induced by Vibrio cholerae cytolysin (hemolysin). Eur. J. Biochem. 247, 209-216
26. Rai, A.K. and Chattopadhyay, K. (2014) Trapping of Vibrio cholerae cytolysin in the membrane-bound monomeric state blocks membrane insertion and functional pore formation by the toxin. J. Biol. Chem. 289, 16978-16987
27. Ray, A., Chattopadhyay, K., Banerjee, K.K. and Biswas, T. (2003) Macrophage distinguishes Vibrio cholerae hemolysin from its protease insensitive oligomer by time dependent and selective expression of CD80-CD86. Immunol. Lett. 89, 143-147
28. Saha, N. and Banerjee, K.K. (1997) Carbohydrate-mediated regulation of interaction of Vibrio cholerae hemolysin with erythrocyte and phospholipid vesicle. J. Biol. Chem. 272, 162-167
29. Mukherjee, G., Biswas, A., Banerjee, K.K. and Biswas, T. (2008) Vibrio cholerae hemolysin is apoptogenic to peritoneal B-1a cells but its oligomer shepherd the cells for IgA response. Mol. Immunol. 45, 266-270
30. Paul, K. and Chattopadhyay, K. (2011) Unfolding distinguishes the Vibrio cholerae cytolysin precursor from the mature form of the toxin. Biochemistry 50, 3936-3945
31. Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254
32. Sakharwade, S.C., Sharma, P.K. and Mukhopadhaya, A. (2013) Vibrio cholerae Porin OmpU induces pro-inflammatory responses, but down-regulates LPS-mediated effects in RAW 264.7, THP-1 and human PBMCs. PloS One 8, e76583
33. Spandidos, A., Wang, X., Wang, H. and Seed, B. (2010) PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification. Nucleic Acids Res. 38, D792-D799
34. Schmittgen, T.D. and Livak, K.J. (2008) Analyzing real-time PCR data by the comparative CT method. Nat. Protoc. 3, 1101-1108
35. Bogdan, C. (2001) Nitric oxide and the immune response. Nat. Immunol. 2, 907-916
36. Laskin, D.L. and Pendino, K.J. (1995) Macrophages and inflammatory mediators in tissue injury. Annu. Rev. Pharmacol. Toxicol. 35, 655-677
37. Bogdan, C., R öllinghoff, M. and Diefenbach, A. (2000) The role of nitric oxide in innate immunity. Immunol. Rev. 173, 17-26
38. Korhonen, R., Lahti, A., Hamalainen, M., Kankaanranta, H. and Moilanen, E. (2002) Dexamethasone inhibits inducible nitric-oxide synthase expression and nitric oxide production by destabilizing mRNA in lipopolysaccharide-treated macrophages. Mol. Pharmacol. 62, 698-704
39. Parihar, A., Eubank, T.D. and Doseff, A.I. (2010) Monocytes and macrophages regulate immunity through dynamic networks of survival and cell death. J. Innate Immun. 2, 204-215
40. Mosser, D.M. and Edwards, J.P. (2008) Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958-969
41. Heinrich, P.C., Castell, J.V. and Andus, T. (1990) Interleukin-6 and the acute phase response. Biochem. J. 265, 621-636
42. Taylor, P.R., Martinez-Pomares, L., Stacey, M., Lin, H.H., Brown, G.D. and Gordon, S. (2005) Macrophage receptors and immune recognition. Annu. Rev. Immunol. 23, 901-944
43. Lee, M.S. and Kim, Y.J. (2007) Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu. Rev. Biochem. 76, 447-480
44. Janeway, Jr, C.A. and Medzhitov, R. (2002) Innate immune recognition. Annu. Rev. Immunol. 20, 197-216
45. Kawai, T. and Akira, S. (2007) TLR signaling. In Seminars in Immunology, pp. 24-32, Elsevier, Amsterdam
46. West, A.P., Koblansky, A.A. and Ghosh, S. (2006) Recognition and signaling by toll-like receptors. Annu. Rev. Cell. Dev. Biol. 22, 409-437
47. Kawai, T. and Akira, S. (2005) Pathogen recognition with Toll-like receptors. Curr. Opin. Immunol. 17, 338-344
48. Ozinsky, A., Underhill, D.M., Fontenot, J.D., Hajjar, A.M., Smith, K.D., Wilson, C.B., Schroeder, L. and Aderem, A. (2000) The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc. Natl. Acad. Sci. U.S.A. 97, 13766-13771
49. Medzhitov, R. (2001) Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1, 135-145
50. Janssens, S. and Beyaert, R. (2002) A universal role for MyD88 in TLR/IL-1R-mediated signaling. Trends Biochem. Sci. 27, 474-482
51. Tak, P.P. and Firestein, G.S. (2001) NF-κ B: a key role in inflammatory diseases. J. Clin. Invest. 107, 7-11
52. Hayden, M.S., West, A.P. and Ghosh, S. (2006) SnapShot: NF-kappaB signaling pathways. Cell 127, 1286-1287
53. Hayden, M.S., West, A.P. and Ghosh, S. (2006) NF-kappaB and the immune response. Oncogene 25, 6758-6780
54. Soucy, T.A., Smith, P.G., Milhollen, M.A., Berger, A.J., Gavin, J.M., Adhikari, S., Brownell, J.E., Burke, K.E., Cardin, D.P., Critchley, S. et al. (2009) An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature 458, 732-736
55. Bessho, R., Matsubara, K., Kubota, M., Kuwakado, K., Hirota, H., Wakazono, Y., Lin, Y.W., Okuda, A., Kawai, M., Nishikomori, R. et al. (1994) Pyrrolidine dithiocarbamate, a potent inhibitor of nuclear factor kappa B (NF-kappa B) activation, prevents apoptosis in human promyelocytic leukemia HL-60 cells and thymocytes. Biochem. Pharmacol. 48, 1883-1889
56. Dong, C., Davis, R.J. and Flavell, R.A. (2002) MAP kinases in the immune response. Annu. Rev. Immunol. 20, 55-72
57. Bode, J.G., Ehlting, C. and Haussinger, D. (2012) The macrophage response towards LPS and its control through the p38(MAPK)-STAT3 axis. Cell Signal. 24, 1185-1194
58. Karahashi, H., Nagata, K., Ishii, K. and Amano, F. (2000) A selective inhibitor of p38 MAP kinase, SB202190, induced apoptotic cell death of a lipopolysaccharide-treated macrophage-like cell line, J774.1. Biochim. Biophys. Acta 1502, 207-223
59. Tsai, Y.R., Wang, Y.J., Lee, M.R., Hsu, M.F. and Wang, J.P. (2013) p38 Mitogen-activated protein kinase and extracellular signal-regulated kinase signaling pathways are not essential regulators of formyl peptide-stimulated p47(phox) activation in neutrophils. Eur. J. Pharmacol. 701, 96-105
60. Karin, M. (1995) The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270, 16483-16486
61. Shaulian, E. and Karin, M. (2002) AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4, E131-E136
62. Zhang, T., Inesta-Vaquera, F., Niepel, M., Zhang, J., Ficarro, S.B., Machleidt, T., Xie, T., Marto, J.A., Kim, N., Sim, T. et al. (2012) Discovery of potent and selective covalent inhibitors of JNK. Chem. Biol. 19, 140-154
63. Bischofberger, M., Iacovache, I. and van der Goot, F.G. (2012) Pathogenic pore-forming proteins: function and host response. Cell Host Microbe 12, 266-275
64. Los, F.C., Randis, T.M., Aroian, R.V. and Ratner, A.J. (2013) Role of pore-forming toxins in bacterial infectious diseases. Microbiol. Mol. Biol. Rev: MMBR 77, 173-207
65. Diacovich, L. and Gorvel, J.P. (2010) Bacterial manipulation of innate immunity to promote infection. Nat. Rev. Microbiol. 8, 117-128
66. Kayagaki, N., Warming, S., Lamkanfi, M., Vande Walle, L., Louie, S., Dong, J., Newton, K., Qu, Y., Liu, J., Heldens, S. et al. (2011) Non-canonical inflammasome activation targets caspase-11. Nature 479, 117-121
67. Malley, R., Henneke, P., Morse, S.C., Cieslewicz, M.J., Lipsitch, M., Thompson, C.M., Kurt-Jones, E., Paton, J.C., Wessels, M.R. and Golenbock, D.T. (2003) Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc. Natl. Acad. Sci. U.S.A. 100, 1966-1971
68. Kebaier, C., Chamberland, R.R., Allen, I.C., Gao, X., Broglie, P.M., Hall, J.D., Jania, C., Doerschuk, C.M., Tilley, S.L. and Duncan, J.A. (2012) Staphylococcus aureus alpha-hemolysin mediates virulence in a murine model of severe pneumonia through activation of the NLRP3 inflammasome. J. Infect. Dis. 205, 807-817
69. Toma, C., Higa, N., Koizumi, Y., Nakasone, N., Ogura, Y., McCoy, A.J., Franchi, L., Uematsu, S., Sagara, J., Taniguchi, S. et al. (2010) Pathogenic vibrio activate NLRP3 inflammasome via cytotoxins and TLR/nucleotide-binding oligomerization domain-mediated NF-kappa B signaling. J. Immunol. 184, 5287-5297
70. Kloft, N., Busch, T., Neukirch, C., Weis, S., Boukhallouk, F., Bobkiewicz, W., Cibis, I., Bhakdi, S. and Husmann, M. (2009) Pore-forming toxins activate MAPK p38 by causing loss of cellular potassium. Biochem. Biophys. Res. Commun. 385, 503-506